Dianomi Therapeutics is a development stage biopharmaceutical company focused on improving the delivery and efficacy of large and small molecules in the treatment of inflammatory diseases.  With an initial focus on osteoarthritis and rheumatoid arthritis, we are working to enhance the safety, efficacy, and duration of effect of therapeutic agents by incorporating them with our proprietary mineral coated microparticle system (MCM).